Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Excited and ready for Shake Shack opening in 2019

2018-07-19 lifestyle.inquirer.net
Known for its Angus beef burgers, chicken sandwiches, flat-top Vienna beef dogs, fresh-spun frozen custard, crinkle-cut fries, craft beer and wine, among other items, Shake Shack has earned a cult following across America and the world over.
SSI SHAK

0
SSI bringing in Shake Shack

2018-07-18 business.inquirer.net
Specialty retailer SSI Group Inc. is bringing New York’s iconic restaurant chain Shake Shack to the Philippines, increasing its portfolio diversification from fashion houses to food and beverage (F&B) operations.
SSI PSKXF SHAK PHSXY PSE

0
Bourse ends at one-month peak on Fed cues

2018-07-18 bworldonline
THE Philippine Stock Exchange index (PSEi) finished at a one-month high on Wednesday, drawing strength from Wall Street’s rise on Federal Reserve Chairman Jerome Powell’s optimistic remarks on the US economy and solid earnings results.
SMIVY SSI SHAK SVTMF MWP AYAAY SM MWIDE ALI AYAAF

0
Stocks edge higher after Fed chair’s ‘dovish’ remarks

2018-07-18 bworldonline
Shares advanced on Wednesday, July 18, boosted by the positive performance of international markets after United States Federal Reserve Chairman Jerome Powell hinted at more flexible changes in monetary policy.
SVTMF PSKXF AYAAY SM SMIVY SSI SHAK MWP PHSXY PSE MWIDE ALI AYAAF

0
Shake Shack’s plan to open in Philippines sends SSI stock soaring

2018-07-18 bworldonline
Shake Shack Inc. is stirring up shares of SSI Group Inc. after the burger chain founded in New York selected the upscale Philippine retailer as its local partner.
SSI SHAK

0
It’s official: Shake Shack is opening in the Philippines in 2019

2018-07-18 lifestyle.inquirer.net
Mabuhay, Manila! Pack the Jeepney – we’re officially headed to the Philippines! 🙌 We’ll be bringin’ the goods to the Pearl of the Orient in spring 2019. Let the countdown begin! 🇵🇭 #shakeshack
SSI SHAK

0
Breaking boundaries in Gucci’s ‘Cyborg’ era

2018-07-14 lifestyle.inquirer.net
Fashion makes the world a lot more interesting. It is only in this colorful and stylish world where creative juices may flow freely.
SSI

0
The new French ambassador can sing Piaf

2018-07-14 lifestyle.inquirer.net
In IAMISM, we consider four areas in people’s lives that are of utmost importance—health, wealth, relationships and success—but we give priority to relationships, which really have the biggest impact on our health and success in life. Yes, even our health, because illnesses fall under the question, “Who is the matter with you?”
SSI

0
‘The Little Prince’ adorns classic writing instrument

2018-07-12 lifestyle.inquirer.net
Montblanc Southeast Asia senior sales manager Nathanael Tan, SSI Group Inc. president AntonHuang, Montblanc Southeast Asia president Matthieu Dupont, Montblanc marketing manager Ben Goh, and Ben Wintle
SSI

0
Why I love shopping at SSI stores

2018-06-09 lifestyle.inquirer.net
Poof! Just like that, half of 2018 is gone! Time is, indeed, the new priceless luxury that we all strive to make the most of.
SSI

0
Shopping perks, promos mark SSI’s 30th anniversary

2018-06-07 lifestyle.inquirer.net
Perks, promos and rewards that underscore its “The Curated Life” campaign—and going digital —mark the SSI Group’s 30th anniversary celebration.
SSI

0
Anton Huang: ‘The future of retail isn’t e-commerce, it isn’t brick-and-mortar stores’

2018-06-07 lifestyle.inquirer.net
Anton T. Huang—who graduated in 1993 from the University of Asia and the Pacific with a degree in humanities and who considers noted economist Bernardo M. Villegas as one of his mentors—had an enviable education no university could offer.
SSI

0
SSI kicks off 30th anniversary celebration

2018-05-31 lifestyle.inquirer.net
Anton T. Huang has reason to feel good these days. SSI Group Inc., according to its report to stakeholders, posted an increase in net income profits in 2017 (19 percent), and the trend continued well into the first quarter of 2018.
SSI

5
Puregold: Pace of Lawson expansion was too slow

2018-05-13 bworldonline
PUREGOLD PRICE Club, Inc. chose to divest from the Lawson chain of convenience stores after its Japanese partner failed to deliver on its expansion program.
PGCMF ITOCY SSI ITOCF AYAAY SEVN PHSVY PRGLY PGOLD ALI AYAAF

0
SSI earnings fall in Q1

2018-05-11 bworldonline
EARNINGS of the SSI Group, Inc. fell in the first three months of the year, dragged by the weakening peso despite a single-digit growth in sales for the period.
SSI RL

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to PSE:SSI / SSI Group, Inc. on message board site Silicon Investor.

Foreign Policy Discussion Thread Classic TA Workplace
Libertarian Discussion Forum Silicon Investor - New feature discussion
Mozilla: Firefox and Thunderbird Discussion ... Quarter to Quarter Aggressive Growth Stocks
Missing Persons SI Thread TGL WHAAAAAAAT! Alerts, thoughts, discussion.
Foreign Affairs Discussion Group NNVC Keeping it real board for pro and con discussions